Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             19 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment Tozuka, Takehiro

144 C p. 71-75
artikel
2 Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? Popat, Sanjay

144 C p. 76-84
artikel
3 Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib Zhou, Yuling

144 C p. 90-91
artikel
4 Contents
144 C p. v-vi
artikel
5 Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations Scheffler, Matthias

144 C p. 40-48
artikel
6 Corrigendum to ‘Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand’ [Lung Cancer volume (124) 233-240]
144 C p. 98
artikel
7 Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand Jaine, Richard

144 C p. 99-106
artikel
8 Editorial Board
144 C p. iii
artikel
9 Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis Breadner, Daniel

144 C p. 57-63
artikel
10 HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model Stockhammer, Paul

144 C p. 20-29
artikel
11 Immune checkpoint inhibitors in special populations. A focus on advanced lung cancer patients Escoin-Perez, Corina

144 C p. 1-9
artikel
12 Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters, Solange

144 C p. 10-19
artikel
13 Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC Mazzaschi, Giulia

144 C p. 30-39
artikel
14 Letter to the editor concerning ‘Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer’ Chen, Donglai

144 C p. 92
artikel
15 LTBP1-ALK: A novel fusion identified in malignant pleural effusions from a patient with advanced lung adenocarcinoma Qian, HuiWen

144 C p. 93-97
artikel
16 Serum cotinine verification of self-reported smoking status among adults eligible for lung cancer screening in the 1999-2018 National Health and Nutrition Examination Survey Liu, Bian

144 C p. 49-56
artikel
17 The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands de Ruiter, Julianne C

144 C p. 64-70
artikel
18 Treatment of pembrolizumab and chemotherapy results in pulmonary lymphoepithelioma-like carcinoma progression through harboring secondary amplification of PI3KCA and IL-7R Chen, Mei-ting

144 C p. 87-89
artikel
19 Upstaging, centrality and survival in early stage non-small cell lung cancer video-assisted surgery Nachira, Dania

144 C p. 85-86
artikel
                             19 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland